These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2593286)

  • 41. [Bone gammagraphy in the diagnosis of uremic renal osteodystrophy].
    Marco Franco JE; Alarcón Zurita A; Peñafiel A; Pizá Buñola C; Morey Molina A; Bestard Palmer J; Mairata Bosch S; Dalmau Diana M
    Rev Clin Esp; 1982 Mar; 164(5):329-32. PubMed ID: 7100549
    [No Abstract]   [Full Text] [Related]  

  • 42. Bone scan appearance of renal osteodystrophy in diabetic chronic renal failure patients.
    So Y; Hyun IY; Lee DS; Ahn C; Chung JK; Kim S; Lee MC; Lee JS; Koh CS
    Radiat Med; 1998; 16(6):417-21. PubMed ID: 9929141
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Super-superscan on a bone scintigraphy.
    Liu Y
    Clin Nucl Med; 2011 Mar; 36(3):227-8. PubMed ID: 21285685
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predictive value of 99mTc pyrophosphate bone scintigraphy for vitamin D trials in uraemia.
    Vanherweghem JL; Dhaene M; Tielemans C; Dratwa M; Verbanck P; Bergmann P; Schoutens A; Fuss M
    Proc Eur Dial Transplant Assoc; 1981; 18():648-51. PubMed ID: 6276883
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Radiophosphate imaging and bone densitometry in renal osteodystrophy.
    Rosenthall L
    Curr Opin Nephrol Hypertens; 1993 Nov; 2(6):956-61. PubMed ID: 7922239
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A simple noninvasive method for assessing renal osteodystrophy.
    Nisbet AP; Shaw P; Taube D; Edwards S; Fogelman I; Maisey M; Mashiter G
    Contrib Nephrol; 1987; 56():205-9. PubMed ID: 3111788
    [No Abstract]   [Full Text] [Related]  

  • 47. (99m)Tc-methylene diphosphonate bone scintigraphy findings in posttransplant distal limb syndrome.
    Derlin T; Busch JD; Bannas P
    Clin Nucl Med; 2014 Jul; 39(7):646-7. PubMed ID: 24873782
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bone scan findings in hypervitaminosis D: case report.
    Fogelman I; McKillop JH; Cowden EA; Fine A; Boyce B; Boyle IT; Greig WR
    J Nucl Med; 1977 Dec; 18(12):1205-7. PubMed ID: 606746
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Usefulness of bone uptake ratio of bone scintigraphy in hemodialysis patients.
    Nishida H; Kaida H; Ishibashi M; Hiromatsu Y; Baba K; Iida S; Okuda S
    Ann Nucl Med; 2005 Apr; 19(2):91-4. PubMed ID: 15909487
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Absent kidney sign associated with symmetrical and uniformly increased uptake of radiopharmaceutical by the skeleton.
    Fogelman I; McKillop JH; Boyle IT; Greig WR
    Eur J Nucl Med; 1977 Dec; 2(4):257-9. PubMed ID: 415864
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Bone scintigraphy in uremic osteodystrophy].
    Mátyus J; Bakó G; Bajnok L; Kakuk G; Leövey A
    Orv Hetil; 1989 Dec; 130(51):2731-5. PubMed ID: 2601956
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The value of scintimetry compared with histomorphology, parathormone assay, densitometry and radiology in renal osteopathy (author's transl)].
    Lingg G; Nebel G; Dorr S
    Rofo; 1982 Jan; 136(1):9-13. PubMed ID: 6212415
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Radiologic aspects of renal osteodystrophy.
    Shapiro R
    Radiol Clin North Am; 1972 Dec; 10(3):557-68. PubMed ID: 4566893
    [No Abstract]   [Full Text] [Related]  

  • 54. [The child's skeleton following renal transplant. A correlation of the radiographic findings to the amount of parathormone (author's transl)].
    Hegenbarth R; Offner G; Hehrmann R; Fritsch R
    Radiologe; 1980 Aug; 20(8):400-5. PubMed ID: 6997923
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [A trial of quantitative analysis of skeletal whole body scintigraphy in renal osteo-dystrophy (author's transl)].
    Kida T; Narita S
    Kaku Igaku; 1978 Dec; 15(8):1191-6. PubMed ID: 219280
    [No Abstract]   [Full Text] [Related]  

  • 56. [Renal disease and scintigraphy with 99mTC-MDP. The value of bone scintigraphy in assessing disease in the kidneys and upper urinary tract].
    Thomsen F; Johnsen A; Jørgensen L; Bouchelouche PN
    Ugeskr Laeger; 1987 May; 149(19):1258-60. PubMed ID: 3603763
    [No Abstract]   [Full Text] [Related]  

  • 57. Renal osteodystrophy--pathophysiological aspects.
    Babić L; Curić N; Cvetinović I; Zupunski A
    Med Pregl; 1993; 46 Suppl 1():38-9. PubMed ID: 8569601
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The use of photon absorptiometry in the diagnosis of renal osteodystrophy.
    Griffiths HJ; Zimmerman RE; Bailey G; Snider R
    Radiology; 1973 Nov; 109(2):277-81. PubMed ID: 4582537
    [No Abstract]   [Full Text] [Related]  

  • 59. Chromium 51 EDTA/technetium 99m MDP plasma ratio to measure total skeletal function.
    Nisbet AP; Edwards S; Lazarus CR; Malamitsi J; Maisey MN; Mashiter GD; Winn PJ
    Br J Radiol; 1984 Aug; 57(680):677-80. PubMed ID: 6235885
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Technetium Tc 99m medronate bone scanning in rhabdomyolysis.
    Frymoyer PA; Giammarco R; Farrar FM; Schroeder ET
    Arch Intern Med; 1985 Nov; 145(11):1991-5. PubMed ID: 4062449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.